Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Medicare Telemedicine Underuse May Not Be Due to Reimbursement Policies

Marilyn Larkin  |  May 11, 2016

NEW YORK (Reuters Health)—Contrary to previous research, mandating commercial insurance reimbursement of telemedicine was not associated with faster growth in Medicare telemedicine use, according to a newly published study.

Dr. Ateev Mehrotra of Harvard Medical School, Boston, and colleagues examined trends in telemedicine utilization by Medicare from 2004–2013 using claims from a 20% random sample of Medicare beneficiaries.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

They defined a telemedicine visit as an encounter “with a GT (via an interactive audio and video telecommunications system) or GQ (via an asynchronous telecommunications system) modifier on the Current Procedural Terminology code or a telemedicine-specific code to a rural beneficiary (29% of all beneficiaries).”

To assess the connection between state parity laws mandating commercial insurance coverage for telemedicine visits—which previous studies suggested might drive higher utilization within Medicare—they compared 2013 Medicare telemedicine use and growth from 2004-2013 in the 12 states that had parity laws and 38 states without such laws as of 2011, they report in JAMA, online May 10.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Telemedicine visits among rural Medicare beneficiaries increased from 7,015 in 2004 to 107,955 in 2013 (annual visit growth rate, 28.0%).

Among the 41,070 (0.7%) rural beneficiaries who received a telemedicine visit in 2013, the mean number of visits came to 2.6. Although most visits occurred in outpatient clinics, 12.5% took place in a hospital or skilled nursing facility. Those with mental health conditions accounted for 78.9% of visits.

Beneficiaries who had a telemedicine visit in 2013 were more likely to be covered by Medicare due to disability, be younger than 65, have more comorbidities, and live in poorer communities than beneficiaries who did not have a telemedicine visit.

Telemedicine use in 2013 came to 8.5 visits per 1,000 beneficiaries in states with parity laws, compared with 6.2 visits per 1,000 beneficiaries in states without parity laws. Growth in visits per capita did not differ between the two sets of states.

“Although the number of Medicare telemedicine visits increased more than 25% a year for the past decade, in 2013, less than 1% of rural Medicare beneficiaries received a telemedicine visit, a lower proportion than in the Veterans Administration, in which 12% of beneficiaries receive some form of telehealth in a given year,” the authors observed.

“Proposed federal legislation would encourage greater use of telemedicine through expanded reimbursement. In contrast to others, we found that state laws that mandate commercial insurance reimbursement of telemedicine were not associated with faster growth in Medicare telemedicine use. Our results emphasize that nonreimbursement factors may be limiting growth of telemedicine including state licensure laws and restrictions that a patient must be hosted at a clinic or facility,” they write.

Page: 1 2 | Single Page
Share: 

Filed under:AppsTechnologyTechnology Tagged with:MedicareMedicare Reimbursementtelemedicine

Related Articles

    The Doctor Will See You Now: Legal & Regulatory Reforms Expand Telemedicine

    March 17, 2020

    In this time of COVID-19, you may be considering ways to deliver routine rheumatologic care via some form of telemedicine. Here are some of the legal considerations.

    Practicing Telemedicine Raises Legal Considerations for Rheumatologists

    July 12, 2016

    With the evolution and advancement of technology, it was only a matter of time before such changes affected the medical industry. Although the concept of telemedicine dates back more than 50 years, emphasis on cost-effective quality healthcare coupled with technological advancements has caused a resurgence of telemedicine in recent years. What constitutes telemedicine largely depends…

    Some Telemedicine Barriers Are Down During COVID-19 Pandemic

    May 15, 2020

    Telerheumatology—which refers to the application of electronic communication technology to clinical encounters from a distance between rheumatologists and their patients—has the potential to extend a workforce projected to experience significant shortfalls, making it more accessible to more patients. Multiple barriers that stood in the way of taking full advantage of this promise are now down—at…

    The ACR Releases New Telemedicine Position Statement

    July 6, 2020

    The rapid expansion of telemedicine in rheumatology, as well as changes to reimbursement and relaxed regulations, during the COVID-19 pandemic has served as an impetus for the ACR to review its position and release a new statement in support of optimized telemedicine practices.

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences